Advertisement

Research Article Free access | 10.1172/JCI114308

Rapid identification of low level hepatitis B-related viral genome in serum.

T J Liang, K J Isselbacher, and J R Wands

Department of Medicine, Harvard Medical School, Massachusetts General Hospital Cancer Center, Charlestown 02129.

Find articles by Liang, T. in: PubMed | Google Scholar

Department of Medicine, Harvard Medical School, Massachusetts General Hospital Cancer Center, Charlestown 02129.

Find articles by Isselbacher, K. in: PubMed | Google Scholar

Department of Medicine, Harvard Medical School, Massachusetts General Hospital Cancer Center, Charlestown 02129.

Find articles by Wands, J. in: PubMed | Google Scholar

Published October 1, 1989 - More info

Published in Volume 84, Issue 4 on October 1, 1989
J Clin Invest. 1989;84(4):1367–1371. https://doi.org/10.1172/JCI114308.
© 1989 The American Society for Clinical Investigation
Published October 1, 1989 - Version history
View PDF
Abstract

A sensitive and specific method has been developed to detect hepatitis B virus (HBV) in serum. The method involves two steps: the capture of viral genome from serum using a high affinity IgM monoclonal antibody directed against a common a domain epitope found on the envelope, and the amplification of viral DNA by the polymerase chain reaction (PCR). The amplification is initiated using "generic" primers derived from the core and pre-core sequences which are highly conserved amongst the hepadnaviruses. This rapid technique detects less than 10 infectious virions and may be useful in the study of individuals with acute and chronic liver disease of unknown etiology.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

Version history
  • Version 1 (October 1, 1989): No description
Advertisement
Advertisement